Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NM-702 in Intermittent Claudication
NCT00102050Phase 2Completed
- Sponsor
- Nissan Chemical
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of parogrelil in intermittent claudication (IC), sponsored by Nissan Chemical. Started Apr 2003; status: completed.
02
Drugs
parogrelil
03
Conditions
intermittent claudication (IC)
Beyond the preview
Go deeper on NCT00102050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102050.